In regulatory terms, the R&D department played an active part in the elaboration of the guidelines relating to substantial amendments, (N)IMP and specific arrangements for non-commercial trials.
In regulatory terms, the R&D department played an active part in the elaboration of the guidelines relating to substantial amendments, (N)IMP and specific arrangements for non-commercial trials.